tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daniel Brims, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).
Analyst Daniel Brims, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 50% that have a potential upside of 10.55% achieved within 30 days. Previously, Daniel Brims worked at HCWAINWRIGHT.
Daniel Brims’s has documented 21 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TTPH, Tetraphase Pharmaceuticals at 08-Sep-2015.
Analyst best performing recommendations are on TTPH (TETRAPHASE PHARMACEUTICALS).
The best stock recommendation documented was for TTPH (TETRAPHASE PHARMACEUTICALS) at 9/9/2015. The price target of $220 was fulfilled within 9 days with a profit of $30.2 (15.91%) receiving and performance score of 17.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
5 years 5 months 5 days ago
(07-May-2020)
1/2 (50%)
$36.05 (72.09%)
304
Buy
$140
6 years 1 months 9 days ago
(02-Sep-2019)
0/4 (0%)
$69.6 (98.86%)
Buy
$4
$1.8 (81.82%)
$380
6 years 5 months 3 days ago
(08-May-2019)
1/4 (25%)
$-16 (-80.00%)
151
Buy
7 years 22 days ago
(19-Sep-2018)
0/3 (0%)
$150.4 (116.05%)
Buy
$140
$137.8 (6263.64%)
$120
7 years 1 months 14 days ago
(28-Aug-2018)
0/3 (0%)
$81.4 (104.62%)
What Year was the first public recommendation made by Daniel Brims?
